Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M |
| Total Depreciation and Amortization | 8.47M | 8.56M | 8.64M | 8.71M | 8.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.09M | 22.20M | 21.73M | 20.27M | 18.97M |
| Change in Net Operating Assets | -7.93M | -7.57M | -7.47M | -4.85M | -5.65M |
| Cash from Operations | -90.50M | -94.04M | -97.84M | -100.44M | -102.07M |
| Capital Expenditure | -1.03M | -1.22M | -1.04M | -1.17M | -1.24M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.16M | -26.68M | 33.73M | 37.34M | 49.95M |
| Cash from Investing | 1.13M | -27.89M | 32.70M | 36.17M | 48.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 47.75M | 47.74M | 47.71M | 51.32M | 4.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -501.00K |
| Cash from Financing | 47.75M | 47.74M | 47.71M | 51.32M | 4.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.62M | -74.19M | -17.43M | -12.96M | -49.31M |